Galderma Group AG (SWX:GALD)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
93.89
-1.54 (-1.61%)
Apr 2, 2025, 5:42 PM CET
48.21%
Market Cap 22.66B
Revenue (ttm) 4.02B
Net Income (ttm) 209.33M
Shares Out 237.41M
EPS (ttm) 0.88
PE Ratio 108.57
Forward PE 41.11
Dividend n/a
Ex-Dividend Date n/a
Volume 529,658
Average Volume 1,458,665
Open 93.51
Previous Close 95.43
Day's Range 91.69 - 94.11
52-Week Range 61.50 - 119.60
Beta n/a
RSI 40.18
Earnings Date Mar 6, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange SIX Swiss Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.